Bio-Techne Inc. - TECH Net earnings per share for the last 12 months

Public company logo of Bio-Techne Corp (TECH)

The year-over-year EPS (TTM) comparison on the GURU.Markets chart demonstrates the pricing power of Bio-Techne Corporation (TECH) within the reference proteins segment, where the 122.00 metric reflects current dynamics. Revenues are based on government science funding and investments from pharmaceutical behemoths. Business resilience is ensured by a broad network of independent laboratories worldwide, which eliminates critical dependence on single counterparties.

Bio-Techne - TECH Earnings per share for the last twelve months (period 02/11/2024 - 11/14/2026)

Techne Corporation - analytical breakdowns and key metrics (TECH)

- market price and analyst price targets:
Market Chart bio-techne.com|TECH - Analyst Consensus Forecast
- issuer market value details:
Market Valuation Bio-Techne Corp|TECH - Real Price to Acquire Entire Company
- book capitalization data:
Accounting Value of a Share Bio-Techne|TECH - Company Book Value|Market Cap to Net Assets Ratio bio-techne.com|TECH - Company Total Assets
- debt burden and liquidity indicators:
Debt to Capital Bio-Techne Corporation|TECH - Long-Term Debt to Capital|Short-Term Debt to Capital Ratio Bio-Techne Inc.|TECH - Company Aggregate Debts|Debts to Net Assets Bio-Techne Corp|TECH - Company Long-Term Debts|Company Current Liabilities Bio-Techne|Quick Ratio bio-techne.com
- financial results and valuation multiples details:
TECH - Company Net Income|Expected Profit Bio-Techne Corporation|TECH - Price to Earnings Ratio|Future Price to Earnings Multiple Bio-Techne Corp|TECH - PEG Multiple|Company Value to EBITDA Bio-Techne Corp|TECH - Profit before payment of interest, taxes and amortization|Net earnings per share for the trailing year Bio-Techne|TECH - Net earnings per share for the last 12 months|Quarterly EPS earnings growth bio-techne.com|TECH - Earnings growth in current year|Consensus forecast of earnings per share growth for next year Bio-Techne Corporation
- revenue and sales details:
TECH - Company Revenue|Company Expected Revenue bio-techne.com|TECH - Price-to-Revenue Ratio|Forward Price-to-Revenue Multiple Bio-Techne Corp
Fundamental company valuation:TECH (bio-techne.com)
Core merchandise of bio-techne.com

Market consensus evaluates Bio-Techne Corporation (TECH) through the lens of its ability to generate profit amidst fierce competition with biotech startups for technological leadership. By analyzing the year-over-year EPS (TTM) comparison, an investor can see the percentage change in net income per share over the last 12 months, allowing for an objective assessment of R&D spending efficiency and the resilience of the company's business model.

Competitor analysis for Bio-Techne Corporation

Net earnings per share for the last four quarters abbott.com ABT|TMO: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months GE HealthCare Technologies Inc.|Net earnings per share for the last 12 months MTD|WAT: Earnings per share for the trailing year|Earnings per share for the last twelve months Bruker Corporation (BRKR)|Net earnings per share for the last 12 months azenta.com AZTA|Net earnings per share (EPS TTM) VREX (Varex Imaging Corporation)|Semler Scientific Inc (SMLR) - Net earnings per one share for the last twelve months|Butterfly iQ - Net earnings per share (EPS TTM)|MLAB (Mesa Laboratories Corp.) - Earnings per share for the last 12 months|QSI: Net earnings per share (EPS TTM)|NNOX - Net earnings per share for the last four quarters|QTRX (Quanterix) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months 908 Devices Inc (MASS)|Net earnings per share (EPS TTM) CV|Net earnings per share (EPS TTM) MaxCyte Inc (MXCT)|Earnings per share for the last twelve months Rapid Micro Biosystems, Inc. RPID|seer.bio - Earnings per share for the last twelve months|HYPR: Net earnings per share for the last 12 months|Earnings per share for the trailing year FONR (FONAR Corp.)|DXR: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Spectral AI Inc. (MDAI)|Earnings per share for the last twelve months VivoSim Labs|ACON - Net earnings per share for the trailing year|Net earnings per share for the last 12 months AKYA (Akoya Biosciences)|Net earnings per share (EPS TTM) ThermoGenesis Holdings, Inc. (THMO)|Net earnings per share (EPS TTM) TLIS (Talis Biomedical Corporation)|Net earnings per share for the last four quarters T2 Biosystems Inc (TTOO)